Nagendran Sukumar — SEC Form 4 filings
SEC reporting owner CIK 1665124. 11 Form 4 filings on record with FilingPulse; latest filed 2026-07-10.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-06-13 to 2026-07-10. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 7 filings — 1,343,276 shares, $6,133,979 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 21.
- Largest priced transaction: sale of 200,000 shares @ $6.24 ($1,248,000) in Taysha Gene Therapies, Inc., filed 2026-07-10.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Taysha Gene Therapies, Inc. (TSHA) | President and Head of R&D, Director | 8 | — | 9 legs · 1,343,276 sh · $6,133,979 | 18 |
| Solid Biosciences Inc. (SLDB) | Director | 3 | — | — | 3 |
Form 4 filings — Nagendran Sukumar
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-10 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Sale (S): 200,000 @ $6.24 | EDGAR |
| 2026-06-11 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 77,500 (derivative) @ $0 | EDGAR |
| 2026-04-13 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Option exercise (M): 19,021 @ $1.71 · Sale (S): 200,000 @ $4.46 · Option exercise (M): 19,021 (derivative) @ $0 | EDGAR |
| 2026-01-27 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Sale (S): 89,132 @ $4.75 · Sale (S): 26,918 @ $4.61 | EDGAR |
| 2026-01-14 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Option exercise (M): 111,324 @ $0.70 · Option exercise (M): 88,676 @ $1.71 · Sale (S): 200,000 @ $4.71 · Grant/award (A): 427,000 @ $0 · Option exercise (M): 111,324 (derivative) @ $0 · Option exercise (M): 88,676 (derivative) @ $0 · +1 more | EDGAR |
| 2025-12-01 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Option exercise (M): 70,172 @ $0.70 · Option exercise (M): 39,953 @ $1.71 · Sale (S): 110,125 @ $4.75 · Option exercise (M): 260,047 @ $1.71 · Sale (S): 260,047 @ $4.51 · Option exercise (M): 70,172 (derivative) @ $0 · +2 more | EDGAR |
| 2025-09-12 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Option exercise (M): 41,150 @ $0.70 · Sale (S): 200,000 @ $3.23 · Option exercise (M): 41,150 (derivative) @ $0 | EDGAR |
| 2025-08-22 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Sale (S): 57,054 @ $2.85 | EDGAR |
| 2025-06-13 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 77,500 (derivative) @ $0 | EDGAR |
| 2025-01-03 | 4 | Taysha Gene Therapies, Inc. (TSHA) | Grant/award (A): 324,500 @ $0 · Grant/award (A): 324,500 (derivative) @ $0 | EDGAR |
| 2024-06-13 | 4 | Solid Biosciences Inc. (SLDB) | Grant/award (A): 34,400 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1665124 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →